Nadege Morisot

Nadege Morisot

Company: Nkarta Therapeutics

Job title: Senior Scientist

Bio:

Nadege Morisot received her PhD in neuroscience from the University of Bordeaux, France followed by a postdoctoral research position at UCSF. Nadege then joined Charles River Laboratories in 2017 where she leveraged her expertise in microdialysis to develop the technique for tumor models to accelerate oncology research. Now Senior Scientist at Nkarta Therapeutics, she is directing preclinical pharmacology studies to support the company’s cellular therapies portfolio. 

Seminars:

Discussion/Q&A 10:00 am

Read more

day: Day Two

Preclinical Evaluation of NKX019, a CD19-targeting CAR NK Cell 9:40 am

NKX019 is a highly potent CD19-directed CAR NK cell therapy with specific cytotoxic activity against CD19+ B-ALL tumors NKX019 displays enhanced in vitro expansion and longer in vivo half-life than non-engineered NK cells NKX019 exhibits advantages compared to CAR19+ T cells including faster cytotoxic kinetics and limited production of cytokines associated with CRSRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.